D3R grand challenge 4: blind prediction of protein–ligand poses, affinity rankings, and relative binding free energies
Journal Article
·
· Journal of Computer-Aided Molecular Design
- Univ. of California San Diego, La Jolla, CA (United States); OSTI
- Univ. of California San Diego, La Jolla, CA (United States)
- Rutgers Univ., New Brunswick, NJ (United States). Inst. for Quantitative Biomedicine, RCSB Protein Data Bank; Univ. of California San Diego, La Jolla, CA (United States). San Diego Supercomputing Center
- Relay Therapeutics, Cambridge, MA (United States)
- Novartis Institutes for BioMedical Research, Emeryville, CA (United States)
- Vertex Pharmaceuticals Inc., Boston, MA (United States)
- Novartis Pharma AG, Basel (Switzerland). Novartis Institutes for BioMedical Research
- Denovicon Therapeutics, San Diego, CA (United States)
- Janssen Research & Development, San Diego, CA (United States)
The Drug Design Data Resource (D3R) aims to identify best practice methods for computer aided drug design through blinded ligand pose prediction and affinity challenges. Herein, we report on the results of Grand Challenge 4 (GC4). GC4 focused on proteins beta secretase 1 and Cathepsin S, and was run in an analogous manner to prior challenges. In Stage 1, participant ability to predict the pose and affinity of BACE1 ligands were assessed. Following the completion of Stage 1, all BACE1 co-crystal structures were released, and Stage 2 tested affinity rankings with co-crystal structures. Finally, we provide an analysis of the results and discuss insights into determined best practice methods.
- Research Organization:
- Rutgers Univ., Piscataway, NJ (United States)
- Sponsoring Organization:
- National Institutes of Health (NIH); National Science Foundation (NSF); USDOE Office of Science (SC)
- Grant/Contract Number:
- SC0019749
- OSTI ID:
- 1803880
- Journal Information:
- Journal of Computer-Aided Molecular Design, Journal Name: Journal of Computer-Aided Molecular Design Journal Issue: 2 Vol. 34; ISSN 0920-654X
- Publisher:
- SpringerCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Outcome of the First wwPDB/CCDC/D3R Ligand Validation Workshop
Protein-ligand binding affinity prediction using multi-instance learning with docking structures
Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functionality
Journal Article
·
2016
· Structure
·
OSTI ID:1260571
+54 more
Protein-ligand binding affinity prediction using multi-instance learning with docking structures
Journal Article
·
2025
· Frontiers in Pharmacology
·
OSTI ID:2516789
+3 more
Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functionality
Journal Article
·
2016
· Journal of Medicinal Chemistry
·
OSTI ID:1506536
+20 more